Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | CES1 | P23141 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.47 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11366183 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL10497315 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL10497507 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL8889723 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL10498007 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL9280452 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL9414538 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL9695930 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 | |
| Pentane SCHEMBL28744442 | 0.98 | CES2 (0.49) | CES2TSHRCES1TP53CYP3A4 | |
| SCHEMBL10435121 | 0.98 | CES2 (0.53) | CES2TSHRCES1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111000761-A | Sunscreen stick containing water-soluble components and preparation method thereof | 苏州绿叶日用品有限公司 | 2020-04-14 | — | — | CN | claimed |
| US-9314488-B2 | Cellular extracts | REGENICS AS (NO) | 2016-04-19 | — | — | US | claimed |
| US-8877253-B2 | Cellular extracts | REGENICS AS (NO) | 2014-11-04 | — | — | US | claimed |
| EP-1278510-B1 | DETERGENT BAR COMPOSITION WITH SKIN LIGHTENING AGENTS AND ORGANIC SUNSCREEN | UNILEVER PLC (GB) | 2005-03-16 | — | — | EP | claimed |
| JP-7118696-A | — | — | None | — | — | JP | disclosed |
| JP-7119038-A | — | — | None | — | — | JP | disclosed |
| EP-4686751-A1 | PROCESS FOR THE PREPARATION OF A DETERGENT CONCENTRATE | Henkel AG & Co. KGaA (DE) | 2026-02-04 | — | — | EP | disclosed |
| US-12458687-B2 | Wound debridement systems | REGENICS AS (NO) | 2025-11-04 | — | — | US | disclosed |
| EP-3866818-B1 | USE OF FISH EGG CELLULAR EXTRACTT FOR WOUND HEALING | REGENICS AS (NO) | 2025-07-23 | — | — | EP | disclosed |
| US-12350352-B2 | Composition for surface modification | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2025-07-08 | — | — | US | disclosed |
| WO-2025131407-A1 | HAND DISHWASHING DETERGENT CONCENTRATE | HENKEL AG & CO. KGAA (DE) | 2025-06-26 | — | — | WO | disclosed |
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | disclosed |
| EP-0506961-A1 | EXTERNAL PREPARATION FOR SKIN | SHISEIDO COMPANY LIMITED (JP) | 1992-10-07 | — | — | EP | disclosed |
| EP-0394464-A1 | OXIRANE DERIVATIVES AND HERBICIDES CONTAINING SAME AS ACTIVE INGREDIENTS | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0390206-A2 | Stable perfluoropolyether emulsions | AUSIMONT S.p.A. (IT) | 1990-10-03 | — | — | EP | disclosed |
| EP-0359909-A2 | Photochromic color rendering regulatory cosmetics | SHISEIDO COMPANY LIMITED (JP) | 1990-03-28 | — | — | EP | disclosed |
| US-4413004-A | FLAVYLIUM SALTS AS VASO-PROTECTIVE AGENTS | INVERNI DELLA BEFFA S.P.A. (IT) | 1983-11-01 | — | — | US | disclosed |
| US-4376781-A | FLAVYLIUM SALTS HAVING HYPOLIPEMIC ANTIINFLAMMATORY, VASO-PROTECTIVE, HYPOCHOLESTEROLEMIC AND HYPOGLYCEMIC ACTIVITY | INVERNI DELLA BEFFA S.P.A. (IT) | 1983-03-15 | — | — | US | disclosed |
| US-4258055-A | USE OF FLAVYLIUM SALTS AS CICATRIZING AGENTS | INVERNI DELLA BEFFA S.P.A. (IT) | 1981-03-24 | — | — | US | disclosed |
| US-4098882-A | SUNSCREEN AGENTS AND PROTECTIVE COATINGS | L'OREAL (FR) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12350352-B2 | Composition for surface modification | CUTA, PTMS, DNMT1 | CES2 1162/4885TSHR 3020/4885CES1 2542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.